chrX-111744768-ACCTCCT-A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001099922.3(ALG13):​c.2830_2835delCCTCCT​(p.Pro944_Pro945del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 591,212 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 209 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., 7 hem., cov: 9)
Exomes 𝑓: 0.0014 ( 0 hom. 202 hem. )

Consequence

ALG13
NM_001099922.3 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.116

Publications

3 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001099922.3
BP6
Variant X-111744768-ACCTCCT-A is Benign according to our data. Variant chrX-111744768-ACCTCCT-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 238294.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00194 (72/37153) while in subpopulation SAS AF = 0.00559 (3/537). AF 95% confidence interval is 0.002. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 9. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.2830_2835delCCTCCT p.Pro944_Pro945del conservative_inframe_deletion Exon 24 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.2830_2835delCCTCCT p.Pro944_Pro945del conservative_inframe_deletion Exon 24 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.00194
AC:
72
AN:
37157
Hom.:
0
Cov.:
9
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00160
Gnomad ASJ
AF:
0.000998
Gnomad EAS
AF:
0.000828
Gnomad SAS
AF:
0.00556
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00256
Gnomad OTH
AF:
0.00471
GnomAD2 exomes
AF:
0.00313
AC:
104
AN:
33243
AF XY:
0.00406
show subpopulations
Gnomad AFR exome
AF:
0.00214
Gnomad AMR exome
AF:
0.00465
Gnomad ASJ exome
AF:
0.00193
Gnomad EAS exome
AF:
0.00227
Gnomad FIN exome
AF:
0.00156
Gnomad NFE exome
AF:
0.00213
Gnomad OTH exome
AF:
0.00300
GnomAD4 exome
AF:
0.00137
AC:
757
AN:
554059
Hom.:
0
AF XY:
0.00129
AC XY:
202
AN XY:
156805
show subpopulations
African (AFR)
AF:
0.00182
AC:
26
AN:
14293
American (AMR)
AF:
0.00226
AC:
37
AN:
16385
Ashkenazi Jewish (ASJ)
AF:
0.00201
AC:
19
AN:
9451
East Asian (EAS)
AF:
0.00150
AC:
23
AN:
15315
South Asian (SAS)
AF:
0.00386
AC:
90
AN:
23306
European-Finnish (FIN)
AF:
0.000378
AC:
7
AN:
18539
Middle Eastern (MID)
AF:
0.00324
AC:
5
AN:
1542
European-Non Finnish (NFE)
AF:
0.00119
AC:
513
AN:
430961
Other (OTH)
AF:
0.00152
AC:
37
AN:
24267
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.430
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00194
AC:
72
AN:
37153
Hom.:
0
Cov.:
9
AF XY:
0.000980
AC XY:
7
AN XY:
7145
show subpopulations
African (AFR)
AF:
0.00101
AC:
10
AN:
9934
American (AMR)
AF:
0.00159
AC:
4
AN:
2518
Ashkenazi Jewish (ASJ)
AF:
0.000998
AC:
1
AN:
1002
East Asian (EAS)
AF:
0.000828
AC:
1
AN:
1208
South Asian (SAS)
AF:
0.00559
AC:
3
AN:
537
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1212
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
78
European-Non Finnish (NFE)
AF:
0.00256
AC:
51
AN:
19918
Other (OTH)
AF:
0.00466
AC:
2
AN:
429
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00106
Hom.:
38

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Uncertain:1Benign:1
Dec 18, 2017
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALG13: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.12
Mutation Taster
=195/5
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56717389; hg19: chrX-110987996; API